CYP2C19 genetic testing for Mavacamten and ischaemic stroke treatment: What does the result mean for cardiovascular prescribers in the UK and Europe?
作者信息
Magavern Emma F, McDermott John H, Caulfield Mark J, Newman William G
机构信息
William Harvey Research Institute, Charterhouse Square, Queen Mary University of London, London EC1M 6BQ, UK.
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester M13 9PL, UK.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):481-483. doi: 10.1093/ehjcvp/pvae040.
PMID:39175266
Abstract
摘要
Zotero 插件